Vascular Grafts Market Size, Share, Trends, Industry Growth and Forecast Report to 2030

The global vascular grafts market size was valued at over USD 2 billion in 2025 and projected to grow t a significant CAGR of around 7% during the forecast period from 2026 to 2030. The market is experiencing consistent growth, driven by the increasing prevalence of cardiovascular diseases, peripheral artery disorders, and a rapidly aging global population. Technological advancements in synthetic and bioengineered graft materials are enhancing durability, biocompatibility, and overall surgical outcomes, supporting wider adoption. The growing preference for minimally invasive procedures and the rising number of vascular surgeries are further contributing to market expansion. Regionally, North America holds the largest share due to advanced healthcare infrastructure and high awareness, whereas Asia-Pacific is emerging as a high-growth region supported by improving medical facilities and rising healthcare investments.

Market Snapshot:

Market Key Insights:

• Endovascular stent grafts dominate the market due to minimally invasive procedures, shorter recovery times, and lower complication rates compared to open surgery.
• Cardiac aneurysm repair drives the highest demand, supported by advanced endovascular aneurysm repair procedures and the rising prevalence of cardiovascular diseases.
• North America holds the largest share, owing to advanced healthcare infrastructure, high procedure volumes, and early adoption of innovative graft technologies.
• Next-generation grafts, including bioengineered, drug-eluting, and hybrid solutions, are improving clinical outcomes and expanding treatment indications.
• Asia-Pacific and Latin America offer growth opportunities due to increasing healthcare access, rising chronic disease prevalence, and expanding medical infrastructure.

Key Factors Driving the Vascular Grafts Market Growth

The vascular grafts market is primarily driven by the increasing global burden of cardiovascular diseases such as coronary artery disease, peripheral artery disease, and aortic aneurysms. The rising prevalence of lifestyle-related risk factors—including diabetes, hypertension, obesity, and smoking—is significantly increasing the number of patients requiring vascular surgeries like bypass procedures and dialysis access. In addition, the rapidly aging population, which is more susceptible to vascular complications, continues to fuel steady demand for vascular grafts across both developed and emerging healthcare systems.

Another key driver is the advancement in graft technologies, particularly the development of synthetic and bioengineered materials that offer improved biocompatibility, flexibility, and long-term performance. The growing shift toward minimally invasive and endovascular procedures is further accelerating adoption due to reduced recovery time and lower surgical risks. A latest fact from the World Health Organization highlights that cardiovascular diseases caused approximately 19.8 million deaths in 2022, accounting for about 32% of all global deaths, underscoring the critical and growing need for effective vascular treatment solutions, including grafts.

Industry Trends Fueling the Global Vascular Grafts Market

The vascular grafts market is witnessing a strong trend toward advanced biomaterials and bioengineered grafts, including synthetic polymers and tissue-engineered solutions that enhance biocompatibility and long-term performance. Innovations such as heparin-bonded grafts and expanded polytetrafluoroethylene (ePTFE) grafts are gaining traction due to their ability to reduce complications like thrombosis and infection. Additionally, there is a growing focus on developing grafts that closely replicate natural blood vessel structures, improving durability and clinical outcomes, particularly in complex cardiovascular procedures.

Another key trend is the rapid shift toward minimally invasive and endovascular procedures, supported by advancements in imaging and surgical precision technologies. These approaches are reducing hospital stays and improving patient recovery times. A recent industry development highlights that MicroPort announced in 2025 that its cumulative global shipments of coronary and vascular-related stent systems surpassed 10 million units, reflecting strong adoption of advanced vascular devices and the growing demand for innovative minimally invasive treatment solutions worldwide.

Future Opportunities Reshaping the Vascular Grafts Market’s Evolution

The vascular grafts market offers strong growth opportunities driven by expanding healthcare access in emerging economies and the rising burden of chronic diseases requiring vascular interventions. Increasing investments in hospital infrastructure, growing awareness of advanced treatment options, and the rising number of dialysis patients are creating substantial demand for vascular grafts. Additionally, the shift toward outpatient and ambulatory surgical settings is opening new avenues for market players to expand their reach and improve patient accessibility to vascular procedures.

Another major opportunity lies in continuous innovation and strategic expansion by key industry players, particularly in biologic and next-generation graft solutions. Companies are increasingly focusing on strengthening their product portfolios through acquisitions and new product development. A recent development highlights that LeMaitre Vascular reported in its 2025–2026 updates that biologic products accounted for over 50% of its total sales, reflecting strong market demand and continued expansion of its biologic graft portfolio through strategic initiatives and acquisitions.

Vascular Grafts Market Challenges:

The vascular grafts market faces several challenges, including the high cost of advanced graft materials and surgical procedures, which can limit adoption in price-sensitive and developing regions. Risks associated with graft failure, infections, thrombosis, and long-term complications also remain significant concerns, impacting patient outcomes and increasing the need for revision surgeries. Additionally, stringent regulatory requirements and lengthy approval processes for new graft technologies can delay product launches and innovation. Limited availability of skilled vascular surgeons and disparities in healthcare infrastructure further restrict market growth, particularly in emerging economies.

Market Segments Insights:

By Product Type: The Endovascular Stent Grafts Segment Dominated the Global Vascular Grafts Market

The global vascular grafts market is bifurcated into product type, raw material, application, end-user, and geography. On the basis of product type, the endovascular stent grafts segment dominated the market, primarily due to the increasing adoption of minimally invasive procedures for the treatment of aortic aneurysms and other complex vascular conditions. These grafts are widely preferred over traditional open surgical grafts because they significantly reduce operative time, hospital stay, and recovery period, while also lowering the risk of complications. The growing availability of advanced imaging technologies and improved stent graft designs—offering better flexibility, sealing, and durability—has further accelerated their adoption across developed healthcare systems.

In addition, the rising global burden of cardiovascular diseases and the increasing number of high-risk and elderly patients, who are often unsuitable for open surgeries, are reinforcing the dominance of endovascular stent grafts. Favorable clinical outcomes, expanding physician preference, and continuous product innovations by key players are also contributing to their leading position. As healthcare systems increasingly shift toward less invasive treatment approaches, this segment is expected to maintain its dominance over other product categories such as hemodialysis access and peripheral vascular grafts.

By Application: The Cardiac Aneurysms Sub-category Holds the Largest Share of Global Vascular Grafts Market

On the basis of application, the global vascular grafts market is further segmented into kidney failure, cardiac aneurysms, and vascular occlusion. The cardiac aneurysms segment dominates the global market, primarily due to the high clinical urgency and widespread adoption of endovascular grafts in treating aortic aneurysms. Minimally invasive procedures such as endovascular aneurysm repair (EVAR) have become the preferred treatment approach, offering reduced surgical risk, shorter hospital stays, and faster recovery compared to open surgeries. The increasing aging population and rising incidence of hypertension and atherosclerosis further contribute to the growing number of aneurysm-related interventions, reinforcing the segment’s leading position.

A recent industry development further supports this dominance: Cook Medical announced in 2025 the commercial availability and first patient treatment using its Zenith Alpha 2 thoracic endovascular graft, following regulatory approval in the U.S. This next-generation device incorporates advanced features such as improved delivery systems and enhanced procedural control, highlighting continuous innovation in aneurysm repair technologies. Such product launches and approvals are accelerating the adoption of endovascular grafts, strengthening the dominance of the cardiac aneurysms segment over other applications like kidney failure and vascular occlusion.

The vascular grafts market research report presents the analysis of each segment from 2020 to 2030 considering 2025 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2026 to 2030.

Global Vascular Grafts Market Segmentation:

By Product Type:

• Endovascular Stent
• Hemodialysis Access
• Peripheral

By Raw Material:

• Polyester
• Polytetrafluoroethylene (PTEF)
• Polyurethane
• Biological Materials

By Application:

• Cardiac Aneurysms
• Kidney Failure
• Vascular Occlusion

By End-User:

• Hospitals
• Ambulatory Surgical Center

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Regional Analysis: North America Leading the Global Vascular Grafts Market

Geographically, North America is the dominant region in the vascular grafts market, driven by its advanced healthcare infrastructure, high adoption of minimally invasive procedures, and strong presence of leading medical device manufacturers. The region benefits from a high prevalence of cardiovascular diseases, well-established reimbursement systems, and widespread access to cutting-edge surgical technologies. Additionally, the availability of skilled vascular surgeons and early adoption of innovative graft materials and endovascular techniques have significantly contributed to the region’s leading market share.

Furthermore, continuous technological advancements, favorable regulatory frameworks, and strong investment in research and development are reinforcing North America’s dominance. The United States, in particular, accounts for a major share due to the high volume of vascular surgeries and increasing use of endovascular grafts for aneurysm repair and other vascular conditions. While other regions such as Asia-Pacific are witnessing rapid growth, North America continues to maintain its leadership position due to its mature healthcare ecosystem and consistent innovation in vascular treatment solutions.

Competitive Landscape:

The Vascular Grafts Market is moderately consolidated and highly competitive, with a mix of large multinational medical device companies and specialized regional players. Leading companies such as Medtronic, W. L. Gore & Associates, Terumo Corporation, Getinge AB, and LeMaitre Vascular dominate the market through strong product portfolios, global distribution networks, and continuous R&D investments. Collectively, the top 5–6 players account for a significant share (around 60%) of the global market, indicating a semi-consolidated structure. These companies compete primarily on innovation, product performance (biocompatibility, durability), and clinical outcomes, particularly in advanced segments such as endovascular stent grafts and bioengineered grafts.

Competition is intensifying due to rapid technological advancements and strategic initiatives such as mergers, acquisitions, and product launches. Key players are focusing on developing next-generation solutions, including bioresorbable, hybrid, and 3D-printed grafts, to differentiate their offerings and improve long-term patient outcomes. At the same time, mid-sized and emerging companies are entering niche segments like dialysis access grafts and complex vascular repairs, increasing market dynamism. Additionally, partnerships with hospitals and expansion into emerging regions such as Asia-Pacific are becoming critical competitive strategies. Overall, the market is innovation-driven, with continuous product development and strategic collaborations shaping the competitive landscape.

Recent Developments:

• In 2025, Medtronic’s Endurant™ Stent Graft System received FDA approval for updated labeling, removing the warning for ruptured abdominal aortic aneurysm (rAAA) and supporting its safe use in emergency EVAR procedures.
• In 2025, L. Gore & Associates’ GORE® VIABAHN® VBX stent graft received an expanded CE‑Mark indication for use as a bridging stent with branched and fenestrated endovascular grafts in complex aortic aneurysm repair.
• In November 2025, Becton, Dickinson and Company (BD) announced that its Revello™ Vascular Covered Stent pivotal AGILITY study achieved full enrollment of the iliac artery cohort, a key step toward broader clinical evaluation in peripheral arterial disease.

Key Companies:

• Medtronic
• Terumo Corporation
• Getinge AB
• L. Gore & Associates
• Becton, Dickinson and Company
• LeMaitre Vascular
• Braun Melsungen AG
• Abbott Laboratories
• Cook Medical
• MicroPort Scientific Corporation
• Endologix
• CryoLife

Global Vascular Grafts Market Outlook

• Rising Adoption of Minimally Invasive Procedures: Increasing preference for endovascular aneurysm repair (EVAR) and other minimally invasive techniques will continue to drive demand for advanced vascular grafts.
• Growth in Emerging Markets: Expanding healthcare infrastructure, rising cardiovascular disease prevalence, and increasing awareness in Asia-Pacific, Latin America, and the Middle East will create new growth opportunities.
• Innovation in Next-Generation Grafts: Development of bioengineered, drug-eluting, hybrid, and 3D-printed grafts will improve patient outcomes and expand clinical applications.
• Strategic Collaborations and Regulatory Approvals: Partnerships, acquisitions, and faster regulatory approvals will support market expansion and wider availability of advanced graft solutions.
• Integration of Digital and Imaging Technologies: Advanced imaging, robotic-assisted procedures, and precision medicine will enhance procedural accuracy and outcomes, reinforcing adoption of vascular grafts globally.

Table of Contents:

1. Preface

1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.4. Assumptions

 

2. Executive Summary

2.1. Global Vascular Grafts Market Portraiture
2.2. Global Vascular Grafts Market, by Product Type, 2025 (USD Mn)
2.3. Global Vascular Grafts Market, by Raw Material, 2025 (USD Mn)
2.4. Global Vascular Grafts Market, by Application, 2025 (USD Mn)
2.5. Global Vascular Grafts Market, by End-User, 2025 (USD Mn)
2.6. Global Vascular Grafts Market, by Geography, 2025 (USD Mn)

 

3. Global Vascular Grafts Market Analysis

3.1. Vascular Grafts Market Overview
3.2. Market Inclination Insights
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Challenges
3.3.3. Opportunities
3.4. Market Trends
3.5. Attractive Investment Proposition
3.6. Competitive Analysis
3.7. Porter’s Five Force Analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrants
3.7.4. Threat of Substitutes
3.7.5. Degree of Competition
3.8. PESTLE Analysis

 

4. Global Vascular Grafts Market by Product Type, 2020 – 2030 (USD Mn)

4.1. Overview
4.2. Endovascular Stent
4.2.1. Market Dynamics (Market Drivers, Market Restraints, Market Opportunities)
4.2.2. Ongoing Trends
4.3. Hemodialysis Access
4.3.1. Market Dynamics (Market Drivers, Market Restraints, Market Opportunities)
4.3.2. Ongoing Trends
4.4. Peripheral
4.4.1. Market Dynamics (Market Drivers, Market Restraints, Market Opportunities)
4.4.2. Ongoing Trends

 

5. Global Vascular Grafts Market by Raw Material, 2020 – 2030 (USD Mn)

5.1. Overview
5.2. Polyester
5.2.1. Market Dynamics (Market Drivers, Market Restraints, Market Opportunities)
5.2.2. Ongoing Trends
5.3. Polytetrafluoroethylene (PTEF)
5.3.1. Market Dynamics (Market Drivers, Market Restraints, Market Opportunities)
5.3.2. Ongoing Trends
5.4. Polyurethane
5.4.1. Market Dynamics (Market Drivers, Market Restraints, Market Opportunities)
5.4.2. Ongoing Trends
5.5. Biological Materials
5.5.1. Market Dynamics (Market Drivers, Market Restraints, Market Opportunities)
5.5.2. Ongoing Trends

 

6. Global Vascular Grafts Market by Application, 2020 – 2030 (USD Mn)

6.1. Overview
6.2. Cardiac Aneurysms
6.2.1. Market Dynamics (Market Drivers, Market Restraints, Market Opportunities)
6.2.2. Ongoing Trends
6.3. Kidney Failure
6.3.1. Market Dynamics (Market Drivers, Market Restraints, Market Opportunities)
6.3.2. Ongoing Trends
6.4. Vascular Occlusion
6.4.1. Market Dynamics (Market Drivers, Market Restraints, Market Opportunities)
6.4.2. Ongoing Trends

 

7. Global Vascular Grafts Market by End-User, 2020 – 2030 (USD Mn)

7.1. Overview
7.2. Hospitals
7.2.1. Market Dynamics (Market Drivers, Market Restraints, Market Opportunities)
7.2.2. Ongoing Trends
7.3. Ambulatory Surgical Center
7.3.1. Market Dynamics (Market Drivers, Market Restraints, Market Opportunities)
7.3.2. Ongoing Trends

 

8. North America Vascular Grafts Market Analysis and Forecast, 2020 – 2030 (USD Mn)

8.1. Overview
8.2. North America Vascular Grafts Market Estimation by Product Type, (2020-2030 USD Mn)
8.3. North America Vascular Grafts Market Estimation by Raw Material, (2020-2030 USD Mn)
8.4. North America Vascular Grafts Market Estimation by Application, (2020-2030 USD Mn)
8.5. North America Vascular Grafts Market Estimation by End-User, (2020-2030 USD Mn)
8.6. North America Vascular Grafts Market Estimation by Country, (2020-2030 USD Mn)
8.6.1. U.S.
8.6.1.1. U.S. Vascular Grafts Market Estimation by Product Type, (2020-2030 USD Mn)
8.6.1.2. U.S. Vascular Grafts Market Estimation by Raw Material, (2020-2030 USD Mn)
8.6.1.3. U.S. Vascular Grafts Market Estimation by Application, (2020-2030 USD Mn)
8.6.1.4. U.S. Vascular Grafts Market Estimation by End-User, (2020-2030 USD Mn)
8.6.2. Canada
8.6.2.1. Canada Vascular Grafts Market Estimation by Product Type, (2020-2030 USD Mn)
8.6.2.2. Canada Vascular Grafts Market Estimation by Raw Material, (2020-2030 USD Mn)
8.6.2.3. U.S. Vascular Grafts Market Estimation by Application, (2020-2030 USD Mn)
8.6.2.4. U.S. Vascular Grafts Market Estimation by End-User, (2020-2030 USD Mn)
8.6.3. Mexico
8.6.3.1. Mexico Vascular Grafts Market Estimation by Product Type, (2020-2030 USD Mn)
8.6.3.2. Mexico Vascular Grafts Market Estimation by Raw Material, (2020-2030 USD Mn)
8.6.3.3. Mexico Vascular Grafts Market Estimation by Application, (2020-2030 USD Mn)
8.6.3.4. Mexico Vascular Grafts Market Estimation by End-User, (2020-2030 USD Mn)

 

9. Europe Vascular Grafts Market Analysis and Forecast, 2020 – 2030 (USD Mn)

9.1. Overview
9.2. Europe Vascular Grafts Market Estimation by Product Type, (2020-2030 USD Mn)
9.3. Europe Vascular Grafts Market Estimation by Raw Material, (2020-2030 USD Mn)
9.4. Europe Vascular Grafts Market Estimation by Application, (2020-2030 USD Mn)
9.5. Europe Vascular Grafts Market Estimation by End-User, (2020-2030 USD Mn)
9.6. Europe Vascular Grafts Market Estimation by Country, (2020-2030 USD Mn)
9.6.1. Germany
9.6.1.1. Europe Vascular Grafts Market Estimation by Product Type, (2020-2030 USD Mn)
9.6.1.2. Europe Vascular Grafts Market Estimation by Raw Material, (2020-2030 USD Mn)
9.6.1.3. Europe Vascular Grafts Market Estimation by Application, (2020-2030 USD Mn)
9.6.1.4. Europe Vascular Grafts Market Estimation by End-User, (2020-2030 USD Mn)
9.6.2. U.K.
9.6.2.1. U.K. Vascular Grafts Market Estimation by Product Type, (2020-2030 USD Mn)
9.6.2.2. U.K. Vascular Grafts Market Estimation by Raw Material, (2020-2030 USD Mn)
9.6.2.3. U.K. Vascular Grafts Market Estimation by Application, (2020-2030 USD Mn)
9.6.2.4. U.K. Vascular Grafts Market Estimation by End-User, (2020-2030 USD Mn)
9.6.3. France
9.6.3.1. France Vascular Grafts Market Estimation by Product Type, (2020-2030 USD Mn)
9.6.3.2. France Vascular Grafts Market Estimation by Raw Material, (2020-2030 USD Mn)
9.6.3.3. France Vascular Grafts Market Estimation by Application, (2020-2030 USD Mn)
9.6.3.4. France Vascular Grafts Market Estimation by End-User, (2020-2030 USD Mn)
9.6.4. Spain
9.6.4.1. Spain Vascular Grafts Market Estimation by Product Type, (2020-2030 USD Mn)
9.6.4.2. Spain Vascular Grafts Market Estimation by Raw Material, (2020-2030 USD Mn)
9.6.4.3. Spain Vascular Grafts Market Estimation by Application, (2020-2030 USD Mn)
9.6.4.4. Spain Vascular Grafts Market Estimation by End-User, (2020-2030 USD Mn)
9.6.5. Italy
9.6.5.1. Italy Vascular Grafts Market Estimation by Product Type, (2020-2030 USD Mn)
9.6.5.2. Italy Vascular Grafts Market Estimation by Raw Material, (2020-2030 USD Mn)
9.6.5.3. Italy Vascular Grafts Market Estimation by Application, (2020-2030 USD Mn)
9.6.5.4. Italy Vascular Grafts Market Estimation by End-User, (2020-2030 USD Mn)
9.6.6. Rest of Europe
9.6.6.1. Rest of Europe Vascular Grafts Market Estimation by Product Type, (2020-2030 USD Mn)
9.6.6.2. Rest of Europe Vascular Grafts Market Estimation by Raw Material, (2020-2030 USD Mn)
9.6.6.3. Rest of Europe Vascular Grafts Market Estimation by Application, (2020-2030 USD Mn)
9.6.6.4. Rest of Europe Vascular Grafts Market Estimation by End-User, (2020-2030 USD Mn)

 

10. Asia Pacific Vascular Grafts Market Analysis and Forecast, 2020 – 2030 (USD Mn)

10.1. Overview
10.2. Asia Pacific Vascular Grafts Market Estimation by Product Type, (2020-2030 USD Mn)
10.3. Asia Pacific Vascular Grafts Market Estimation by Raw Material, (2020-2030 USD Mn)
10.4. Asia Pacific Vascular Grafts Market Estimation by Application, (2020-2030 USD Mn)
10.5. Asia Pacific Vascular Grafts Market Estimation by End-User, (2020-2030 USD Mn)
10.6. Asia Pacific Vascular Grafts Market Estimation by Country, (2020-2030 USD Mn)
10.6.1. China
10.6.1.1. China Vascular Grafts Market Estimation by Product Type, (2020-2030 USD Mn)
10.6.1.2. China Vascular Grafts Market Estimation by Raw Material, (2020-2030 USD Mn)
10.6.1.3. China Vascular Grafts Market Estimation by Application, (2020-2030 USD Mn)
10.6.1.4. China Vascular Grafts Market Estimation by End-User, (2020-2030 USD Mn)
10.6.2. Japan
10.6.2.1. Japan Vascular Grafts Market Estimation by Product Type, (2020-2030 USD Mn)
10.6.2.2. Japan Vascular Grafts Market Estimation by Raw Material, (2020-2030 USD Mn)
10.6.2.3. Japan Vascular Grafts Market Estimation by Application, (2020-2030 USD Mn)
10.6.2.4. Japan Vascular Grafts Market Estimation by End-User, (2020-2030 USD Mn)
10.6.3. India
10.6.3.1. India Vascular Grafts Market Estimation by Product Type, (2020-2030 USD Mn)
10.6.3.2. India Vascular Grafts Market Estimation by Raw Material, (2020-2030 USD Mn)
10.6.3.3. India Vascular Grafts Market Estimation by Application, (2020-2030 USD Mn)
10.6.3.4. India Vascular Grafts Market Estimation by End-User, (2020-2030 USD Mn)
10.6.4. South Korea
10.6.4.1. South Korea Vascular Grafts Market Estimation by Product Type, (2020-2030 USD Mn)
10.6.4.2. South Korea Vascular Grafts Market Estimation by Raw Material, (2020-2030 USD Mn)
10.6.4.3. South Korea Vascular Grafts Market Estimation by Application, (2020-2030 USD Mn)
10.6.4.4. South Korea Vascular Grafts Market Estimation by End-User, (2020-2030 USD Mn)
10.6.5. Rest of Asia Pacific
10.6.5.1. Rest of Asia Pacific Vascular Grafts Market Estimation by Product Type, (2020-2030 USD Mn)
10.6.5.2. Rest of Asia Pacific Vascular Grafts Market Estimation by Raw Material, (2020-2030 USD Mn)
10.6.5.3. Rest of Asia Pacific Vascular Grafts Market Estimation by Application, (2020-2030 USD Mn)
10.6.5.4. Rest of Asia Pacific Vascular Grafts Market Estimation by End-User, (2020-2030 USD Mn)

 

11. Latin America (LATAM) Vascular Grafts Market Analysis and Forecast, 2020 – 2030 (USD Mn)

11.1. Overview
11.2. Latin America (LATAM) Vascular Grafts Market Estimation by Product Type, (2020-2030 USD Mn)
11.3. Latin America (LATAM) Vascular Grafts Market Estimation by Raw Material, (2020-2030 USD Mn)
11.4. Latin America (LATAM) Vascular Grafts Market Estimation by Application, (2020-2030 USD Mn)
11.5. Latin America (LATAM) Vascular Grafts Market Estimation by End-User, (2020-2030 USD Mn)
11.6. Latin America (LATAM) Vascular Grafts Market Estimation by Country, (2020-2030 USD Mn)
11.6.1. Brazil
11.6.1.1. Brazil Vascular Grafts Market Estimation by Product Type, (2020-2030 USD Mn)
11.6.1.2. Brazil Vascular Grafts Market Estimation by Raw Material, (2020-2030 USD Mn)
11.6.1.3. Brazil Vascular Grafts Market Estimation by Application, (2020-2030 USD Mn)
11.6.1.4. Brazil Vascular Grafts Market Estimation by End-User, (2020-2030 USD Mn)
11.6.2. Argentina
11.6.2.1. Argentina Vascular Grafts Market Estimation by Product Type, (2020-2030 USD Mn)
11.6.2.2. Argentina Vascular Grafts Market Estimation by Raw Material, (2020-2030 USD Mn)
11.6.2.3. Argentina Vascular Grafts Market Estimation by Application, (2020-2030 USD Mn)
11.6.2.4. Argentina Vascular Grafts Market Estimation by End-User, (2020-2030 USD Mn)
11.6.3. Rest of Latin America
11.6.3.1. Rest of Latin America Vascular Grafts Market Estimation by Product Type, (2020-2030 USD Mn)
11.6.3.2. Rest of Latin America Vascular Grafts Market Estimation by Raw Material, (2020-2030 USD Mn)
11.6.3.3. Rest of Latin America Vascular Grafts Market Estimation by Application, (2020-2030 USD Mn)
11.6.3.4. Rest of Latin America Vascular Grafts Market Estimation by End-User, (2020-2030 USD Mn)

 

12. Middle East and Africa Vascular Grafts Market Analysis and Forecast, 2020 – 2030 (USD Mn)

12.1. Overview
12.2. MEA Vascular Grafts Market Estimation by Product Type, (2020-2030 USD Mn)
12.3. MEA Vascular Grafts Market Estimation by Raw Material, (2020-2030 USD Mn)
12.4. MEA Vascular Grafts Market Estimation by Application, (2020-2030 USD Mn)
12.5. MEA Vascular Grafts Market Estimation by End-User, (2020-2030 USD Mn)
12.6. MEA Vascular Grafts Market Estimation, by Country, (2020-2030 USD Mn)
12.6.1. GCC
12.6.1.1. GCC Vascular Grafts Market Estimation by Product Type, (2020-2030 USD Mn)
12.6.1.2. GCC Vascular Grafts Market Estimation by Raw Material, (2020-2030 USD Mn)
12.6.1.3. GCC Vascular Grafts Market Estimation by Application, (2020-2030 USD Mn)
12.6.1.4. GCC Vascular Grafts Market Estimation by End-User, (2020-2030 USD Mn)
12.6.2. South Africa
12.6.2.1. South Africa Vascular Grafts Market Estimation by Product Type, (2020-2030 USD Mn)
12.6.2.2. South Africa Vascular Grafts Market Estimation by Raw Material, (2020-2030 USD Mn)
12.6.2.3. South Africa Vascular Grafts Market Estimation by Application, (2020-2030 USD Mn)
12.6.2.4. South Africa Vascular Grafts Market Estimation by End-User, (2020-2030 USD Mn)
12.6.3. Rest of MEA
12.6.3.1. Rest of MEA Vascular Grafts Market Estimation by Product Type, (2020-2030 USD Mn)
12.6.3.2. Rest of MEA Vascular Grafts Market Estimation by Raw Material, (2020-2030 USD Mn)
12.6.3.3. Rest of MEA Vascular Grafts Market Estimation by Application, (2020-2030 USD Mn)
12.6.3.4. Rest of MEA Vascular Grafts Market Estimation by End-User, (2020-2030 USD Mn)

 

13. Competitive Landscape

13.1. Company Market Share Analysis, 2025
13.2. Competitive Dashboard
13.3. Competitive Benchmarking
13.4. Geographic Presence Heatmap Analysis
13.5. Company Evolution Matrix
13.5.1. Star
13.5.2. Pervasive
13.5.3. Emerging Leader
13.5.4. Participant
13.6. Strategic Analysis Heatmap Analysis
13.7. Key Developments and Growth Strategies
13.7.1. Mergers and Acquisitions
13.7.2. New Product Launch
13.7.3. Joint Ventures
13.7.4. Others

 

14. Company Profiles

14.1. Medtronic
14.1.1. Business Description
14.1.2. Financial Health and Budget Allocation
14.1.3. Product Positions/Portfolio
14.1.4. Recent Development
14.1.5. SWOT Analysis
14.2. Terumo Corporation
14.3. Getinge AB
14.4. L. Gore & Associates
14.5. Becton, Dickinson and Company
14.6. LeMaitre Vascular
14.7. Braun Melsungen AG
14.8. Abbott Laboratories
14.9. Cook Medical
14.10. MicroPort Scientific Corporation
14.11. Endologix
14.12. CryoLife

Frequently Asked Questions – Vascular Grafts Market